Alpha Cognition is trading 9.73% up at $9.76, possibly reflecting continued investor interest after second-quarter results.
- Results showed $6.0 million in ZUNVEYL net product revenue; H.C. Wainwright later raised its price target to $20 from $18.
- No new company-specific announcement dated August 20, 2026 was identified, and coverage does not directly attribute today’s gain to either catalyst.
- Biotech is declining, while current reliable volume and activity data were unavailable.